Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2100 of 3284 entries
View as:

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06350097 Org: User:
Start: 04/29/24 End: 05/25/32 Due: 05/25/33

A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04198558 Org: User:
Start: 11/29/19 End: 02/23/22 Due: 02/23/23

Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00684502 Org: User:
Start: 01/31/08 End: 11/30/08 Due: 11/30/09

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05375760 Org: User:
Start: 06/09/22 End: 10/04/23 Due: 10/04/24

A Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1446 Administered for 4 Weeks in Elderly Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00997308 Org: User:
Start: 10/31/09 End: 12/31/09 Due: 12/31/10

Single + Multiple Ascending Dose and Food Effect Study of AZD7986 in Healthy Volunteers, PK, PD and Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT02303574 Org: User:
Start: 12/03/14 End: 08/03/16 Due: 08/03/17

ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00014690 Org: User:
Start: 03/31/01 End: 02/29/04 Due: 02/28/05

EMR Data to Assess Monitoring of Patients Treated With Quetiapine

Phase: N/A Priority: Normal
NCT ID: NCT01793324 Org: User:
Start: 04/30/12 End: 06/30/13 Due: 06/30/14

S-CEI of Nexium in Paediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT03562026 Org: User:
Start: 06/28/18 End: 11/05/20 Due: 11/05/21

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT03953300 Org: User:
Start: 10/17/19 End: 09/09/26 Due: 09/09/27

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00475956 Org: User:
Start: 05/31/07 End: 10/31/09 Due: 10/31/10

Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02446899 Org: User:
Start: 07/09/15 End: 09/27/18 Due: 09/27/19

Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00252785 Org: User:
Start: 10/31/05 End: 11/30/06 Due: 11/30/07

A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT00419952 Org: User:
Start: 02/28/07 End: 11/30/09 Due: 11/30/10

Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR

Phase: N/A Priority: Normal
NCT ID: NCT00750087 Org: User:
Start: 08/31/08 End: 09/30/09 Due: 09/30/10

Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01579578 Org: User:
Start: 04/30/12 End: 03/31/13 Due: 03/31/14

Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01176682 Org: User:
Start: 08/31/10 End: 08/31/11 Due: 08/31/12

Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00444275 Org: User:
Start: 03/31/07 End: 10/31/08 Due: 10/31/09

Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00777153 Org: User:
Start: 10/31/08 End: 09/30/16 Due: 09/30/17

Retrospective Survey for Patients With Hypertension and Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00681278 Org: User:
Start: 04/30/08 End: 10/31/08 Due: 10/31/09

Patients' Compliance to Home Nebulizer Therapy for Children's Asthma in China

Phase: N/A Priority: Normal
NCT ID: NCT03156998 Org: User:
Start: 07/25/17 End: 05/09/18 Due: 05/09/19

Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents

Phase: N/A Priority: Normal
NCT ID: NCT00099333 Org: User:
Start: 02/29/04 End: 08/31/05 Due: 08/31/06

Forxiga CKD Japan Post-Marketing Surveillance (PMS)

Phase: N/A Priority: Normal
NCT ID: NCT05306210 Org: User:
Start: 04/12/22 End: 10/08/24 Due: 10/08/25

A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China

Phase: N/A Priority: Normal
NCT ID: NCT05271266 Org: User:
Start: 03/22/22 End: 12/06/23 Due: 12/06/24

Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03616587 Org: User:
Start: 10/11/18 End: 11/28/25 Due: 11/28/26